STAT

To save a young woman besieged by superbugs, scientists hunt a killer virus

Mark Smith wants to inject his dying daughter with a virus in hopes it might kill the bacteria rooted in her lungs. First, he has to find the right virus.

The word from the doctors came early this week: They had tried one cocktail of antibiotics after another, but Mallory Smith’s fever and chill and chest rattle were only getting worse. They were out of options.

Her father, though, had an idea. He wanted to infect Mallory with a virus — one carefully selected to kill the bacteria that had colonized her lungs. It was hardly foolproof, and it would require special emergency approval from the federal government, but it might just do what the antibiotics couldn’t.

First, they needed the virus. Mark Smith had read about a similar case from 2016. He’d already been emailing with the scientists involved. Now, he gave them the go-ahead.

The next day, a strange tweet went out from Steffanie Strathdee, the associate dean of global health science at the University of California, San Diego: “#Phage researchers! I am working with a team to get Burkholderia cepacia phages to treat a 25 y old woman with CF whose infection has failed all #antibiotics. We need lytic non-lysogenic phage URGENTLY to find suitable phage matches.”

In other words, she was on the hunt for a bacteriophage — literally, a bacteria-eater — that would attack the antibiotic-resistant Burkholderia cepacia in Mallory’s lungs. It couldn’t be just any old phage. It had to be a virus that would actually explode the bacteria, instead of peacefully nestling inside them for a while.

Strathdee had worked as a phage-wrangler before. Her husband, in fact, had been the patient Smith had read about. A combination of phage therapy and antibiotics woke him from a coma in 2016. After that, others began to seek

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.

Related Books & Audiobooks